Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07485764
What this trial is testing

Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients

Who this might be right for
PsoriasisPlaque PsoriasisModerate-to-severe Plaque Psoriasis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Large-scale testing (Phase 3)Study completedNCT02561806
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 302
Large-scale testing (Phase 3)Ended earlyNCT00833053
What this trial is testing

Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 39
Large-scale testing (Phase 3)Study completedNCT04785326
What this trial is testing

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Dong-A ST Co., Ltd. 598
Testing effectiveness (Phase 2)Active Not RecruitingNCT06875934
What this trial is testing

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 145
Testing effectiveness (Phase 2)UnknownNCT05604898
What this trial is testing

Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 139
Early research (Phase 1)WithdrawnNCT01260844
What this trial is testing

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Who this might be right for
Moderate to Severe Plaque Psoriasis
Abbott 12
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Large-scale testing (Phase 3)Looking for participantsNCT07265284
What this trial is testing

Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 104
Testing effectiveness (Phase 2)Study completedNCT03010527
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 217
Not applicableStudy completedNCT00678470
What this trial is testing

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
University of California, San Francisco 18
Early research (Phase 1)Ended earlyNCT01948271
What this trial is testing

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 3
Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Not applicableLooking for participantsNCT07039110
What this trial is testing

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie 700
Large-scale testing (Phase 3)Study completedNCT06011733
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 133
Testing effectiveness (Phase 2)Study completedNCT01230138
What this trial is testing

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH 252
Large-scale testing (Phase 3)Study completedNCT03255382
What this trial is testing

Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy

Who this might be right for
Psoriasis
AbbVie 120
Testing effectiveness (Phase 2)Study completedNCT00852670
What this trial is testing

ACT-128800 in Psoriasis

Who this might be right for
Plaque Psoriasis
Actelion 66
Testing effectiveness (Phase 2)Study completedNCT02899988
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 205
Large-scale testing (Phase 3)Active Not RecruitingNCT06630559
What this trial is testing

Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Celltrion 153
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation